Short-term Effects of a Systematized Bladder Training Program for Idiopathic Overactive Bladder: A Prospective Study

Hahn-Ey Lee, Sung Yong Cho, Sangim Lee, Myong Kim, Seung-June Oh, Hahn-Ey Lee, Sung Yong Cho, Sangim Lee, Myong Kim, Seung-June Oh

Abstract

Purpose: This study was to investigate whether a systematized bladder training (BT) program is effective for patients with idiopathic overactive bladder (OAB).

Methods: A prospective study was conducted on 105 patients with OAB from March 2009 to November 2011. We developed a 30 minutes BT program, which consisted of first, refraining from going to the bathroom after feeling an urge to void, second, in order to stop thinking about voiding, ceasing action and thought temporarily, and third, performing pelvic floor exercises 5 to 6 times. Before and after BT, the patients filled out voiding diaries as well as the following questionnaires; International Consultation on Incontinence Questionnaire for overactive bladder (ICIQ-OAB), International Prostate Symptom Score (IPSS), overactive bladder questionnaire (OAB-q), the short form 36-item health survey (SF-36) questionnaire, the work productivity and activity impairment questionnaire, and a patients' perception of treatment benefit (PPTB).

Results: A final analysis was performed from on 85 patients (38 male, 47 female) with idiopathic OAB. After the first BT, the results of the ICIQ-OAB showed improvement in frequency, nocturia, and urgency (P<0.05), and all domains of IPSS questionnaires showed significant improvement (P<0.05). Among the SF-36 domains, the role-physical domain showed significant improvement after the first BT, and the general health domain showed significant improvement after the second. The voiding diaries showed statistically significant changes in maximal voided volume after the first BT, and nocturia index and nocturnal polyuria index after the second BT. According to the PPTB questionnaire, the perceived usefulness of BT increased after each session, and almost all of the patients replied that BT improved their symptoms.

Conclusions: Our results demonstrated that BT was effective in improving many OAB related symptoms and quality of life in patients with idiopathic OAB. More clinical application of BT could be implemented in the future.

Keywords: Behavior modification; Overactive urinary bladder; Quality of life.

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

References

    1. Abrams P, Artibani W, Cardozo L, Dmochowski R, van Kerrebroeck P, Sand P, et al. Reviewing the ICS 2002 terminology report: the ongoing debate. Neurourol Urodyn. 2009;28:287.
    1. Hubeaux K, Deffieux X, Raibaut P, Le Breton F, Jousse M, Amarenco G. Evidence for autonomic nervous system dysfunction in females with idiopathic overactive bladder syndrome. Neurourol Urodyn. 2011;30:1467–1472.
    1. Griebling TL. Best treatment for overactive bladder if behavioral treatment and anticholinergics fail. Sacral nerve stimulation. J Urol. 2011;185:2024–2026.
    1. Arnold J, McLeod N, Thani-Gasalam R, Rashid P. Overactive bladder syndrome: management and treatment options. Aust Fam Physician. 2012;41:878–883.
    1. Van Kerrebroeck PE. Does conservative management really benefit patients with OAB? Curr Urol Rep. 2012;13:348–355.
    1. Wyman JF, Burgio KL, Newman DK. Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence. Int J Clin Pract. 2009;63:1177–1191.
    1. Cho SY, Lee SL, Kim IS, Koo DH, Kim HJ, Oh SJ. Short-term effects of systematized behavioral modification program for nocturia: a prospective study. Neurourol Urodyn. 2012;31:64–68.
    1. Acquadro C, Kopp Z, Coyne KS, Corcos J, Tubaro A, Choo MS, et al. Translating overactive bladder questionnaires in 14 languages. Urology. 2006;67:536–540.
    1. Oh SJ, Son H, Kim SW, Lee KS, Choo MS, Kim SO, et al. Psychometric properties of the Korean version of the overactive bladder questionnaire (OAB-q) in a Korean population. Int Neurourol J. 2012;16:77–85.
    1. Han SS, Kim KW, Na KY, Chae DW, Kim YS, Kim S, et al. Quality of life and mortality from a nephrologist's view: a prospective observational study. BMC Nephrol. 2009;10:39.
    1. Kosinski M, Keller SD, Hatoum HT, Kong SX, Ware JE., Jr The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: tests of data quality, scaling assumptions and score reliability. Med Care. 1999;37(5 Suppl):MS10–MS22.
    1. Kim HS, Harada K, Miyashita M, Lee EA, Park JK, Nakamura Y. Use of senior center and the health-related quality of life in Korean older adults. J Prev Med Public Health. 2011;44:149–156.
    1. Coyne KS, Sexton CC, Thompson CL, Clemens JQ, Chen CI, Bavendam T, et al. Impact of overactive bladder on work productivity. Urology. 2012;80:97–103.
    1. Pleil AM, Coyne KS, Reese PR, Jumadilova Z, Rovner ES, Kelleher CJ. The validation of patient-rated global assessments of treatment benefit, satisfaction, and willingness to continue--the BSW. Value Health. 2005;8(Suppl 1):S25–S34.
    1. Waine E, Hashim H, Abrams P. Management of the overactive bladder: a review of pharmacological therapies and methods used by the urological specialist. Can J Urol. 2007;14:3478–3488.
    1. Sung W, You H, Yoon TY, Lee SJ. Socioeconomic costs of overactive bladder and stress urinary incontinence in Korea. Int Neurourol J. 2012;16:23–29.
    1. Burgio KL. Behavioral treatment of urinary incontinence, voiding dysfunction, and overactive bladder. Obstet Gynecol Clin North Am. 2009;36:475–491.
    1. Burgio KL, Goode PS, Johnson TM, Hammontree L, Ouslander JG, Markland AD, et al. Behavioral versus drug treatment for overactive bladder in men: the Male Overactive Bladder Treatment in Veterans (MOTIVE) Trial. J Am Geriatr Soc. 2011;59:2209–2216.
    1. Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 2012;188(6 Suppl):2455–2463.
    1. Anger JT, Le TX, Nissim HA, Rogo-Gupta L, Rashid R, Behniwal A. How dry is "OAB-dry"? Perspectives from patients and physician experts. J Urol. 2012;188:1811–1815.
    1. Ware JE, Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care. 1995;33(4 Suppl):AS264–AS279.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner